Thursday, Apr. 19, 2012
This landmark study could revolutionize the diagnosis and treatment of 48,000 sufferers every year.
- DELYTH MORGAN,
- chief executive of the Breast Cancer Campaign, on a scientific breakthrough that could bring women closer to personalized treatments, known as the holy grail of cancer care